Literature DB >> 3760870

Effects of phenylalanine on the release of endogenous dopamine from rat striatal slices.

J D Milner, K Irie, R J Wurtman.   

Abstract

We examined the effect of phenylalanine (50-400 microM) on the electrically stimulated release of endogenous 3,4-dihydroxyphenylethylamine (dopamine or DA) from superfused rat striatal slices. In the absence of tyrosine, phenylalanine (25 microM) partially sustained DA release, but less well than an equimolar concentration of tyrosine. In the presence of tyrosine (50 microM), phenylalanine (in concentrations of greater than or equal to 200 microM) inhibited DA release into the superfusate. This inhibition was not associated with changes in tissue levels of tyrosine or DA, nor was it mimicked by addition of high concentrations of tyrosine or leucine to the medium. We conclude that phenylalanine is a less effective precursor of DA in rat striatum than tyrosine and that it can also act to inhibit DA synthesis, depending on its concentration.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3760870     DOI: 10.1111/j.1471-4159.1986.tb00777.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

1.  Effect of L-dopa on visual evoked potentials and neuropsychological tests in adult phenylketonuria patients.

Authors:  K Ullrich; J Weglage; C Oberwittler; M Pietsch; B Fünders; H von Eckardstein; J P Colombo
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

2.  The effect of phenylalanine on DOPA synthesis in PC12 cells.

Authors:  F R DePietro; J D Fernstrom
Journal:  Neurochem Res       Date:  1998-07       Impact factor: 3.996

Review 3.  Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults.

Authors:  Stephanie M Matt; Peter J Gaskill
Journal:  Brain Res       Date:  2019-08-21       Impact factor: 3.252

4.  Effects of running the Boston marathon on plasma concentrations of large neutral amino acids.

Authors:  L A Conlay; R J Wurtman; I Lopez G-Coviella; J K Blusztajn; C A Vacanti; M Logue; M During; B Caballero; T J Maher; G Evoniuk
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

5.  Effects of oral aspartame on plasma phenylalanine in humans and experimental rodents. Short note.

Authors:  R J Wurtman; T J Maher
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

6.  Regression of neuropsychological deficits in early-treated phenylketonurics during adolescence.

Authors:  J Weglage; M Pietsch; J Denecke; A Sprinz; R Feldmann; M Grenzebach; K Ullrich
Journal:  J Inherit Metab Dis       Date:  1999-08       Impact factor: 4.982

7.  Tyrosine depletion alters cortical and limbic blood flow but does not modulate spatial working memory performance or task-related blood flow in humans.

Authors:  Kathryn A Ellis; Mitul A Mehta; P J Naga Venkatesha Murthy; Sarah F B McTavish; Pradeep J Nathan; Paul M Grasby
Journal:  Hum Brain Mapp       Date:  2007-11       Impact factor: 5.038

Review 8.  Pharmacological effects of phenylalanine on seizure susceptibility: an overview.

Authors:  P Y Sze
Journal:  Neurochem Res       Date:  1989-02       Impact factor: 3.996

Review 9.  Possible neurologic effects of aspartame, a widely used food additive.

Authors:  T J Maher; R J Wurtman
Journal:  Environ Health Perspect       Date:  1987-11       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.